Tops & Flops Stocks
| Security ▲ | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Olympus Corp. | 0.000% | 4.381% | 6.468% | -16.095% | 4.462% | -21.909% | 34.669% |
| Omeros Corp. | -0.120% | 17.550% | 9.910% | -25.997% | 8.998% | -76.903% | -79.713% |
| Omnicell Inc. | 9.520% | 7.813% | 9.524% | -53.613% | -21.143% | -76.000% | -61.994% |
| Oncimmune Holdings PLC | 3.250% | 3.252% | 22.115% | -40.094% | -4.511% | -89.675% | -73.263% |
| OncoCyte Corp | -3.610% | - | - | - | - | - | - |
| Oncolys Biopharma Inc. | 2.790% | - | - | - | - | - | - |
| Oncolytics Biotech | -4.730% | - | - | - | - | - | - |
| Oncopeptides AB | 2.250% | -0.792% | -50.396% | -65.429% | -63.978% | - | - |
| Oncotherapy Science Inc. | 2.330% | 3.529% | -11.111% | -60.000% | -32.308% | -89.943% | -90.900% |
| Onxeo S.A. | -10.020% | -1.101% | -4.602% | -62.175% | -28.845% | -83.982% | -86.949% |
| Opko Health Inc. | -1.990% | 3.324% | -3.794% | -8.830% | -14.933% | -64.295% | -42.276% |
| Opsens Inc | -0.580% | - | - | - | - | - | - |
| Optibiotix Health plc | -2.910% | 1.010% | -6.542% | 81.818% | -31.973% | -64.602% | - |
| Oragenics Inc. | - | - | - | - | - | - | - |
| Oramed Pharmaceuticals | 0.050% | 2.244% | -9.591% | -13.489% | 3.355% | -76.331% | -32.749% |
| Orasure Tech | 3.660% | 4.508% | -7.273% | -17.742% | -31.544% | -33.351% | -40.725% |
| Orexigen Therapeutics Inc. | - | - | - | - | - | - | - |
| Organigram Holdings Inc. | 0.230% | -1.147% | -12.130% | -8.004% | 33.643% | -80.147% | -93.507% |
| Organovo Holdings Inc. | -5.480% | 2.872% | 2.220% | -43.516% | -5.750% | -84.808% | -94.698% |
| Orion Corp. B | 0.220% | 0.892% | 9.366% | -15.322% | -8.099% | 0.333% | 21.681% |
| Orpea Nom. | -6.150% | - | - | - | - | - | - |
| Orthofix Medical Inc. | 0.830% | 0.833% | -6.202% | -24.845% | -1.626% | -66.575% | -75.139% |
| Ose Pharma International S.A. | 0.480% | 10.498% | 22.244% | 67.838% | 41.943% | - | - |
| Osmotica Pharmaceuticals PLC | 8.780% | - | - | - | - | - | - |
| Otonomy Inc. | - | - | - | - | - | - | - |